Page last updated: 2024-08-25

efaroxan and Astrocytosis

efaroxan has been researched along with Astrocytosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cahill, CM; Grenier, P; Olmstead, MC; Wiercigroch, D	1

Other Studies

1 other study(ies) available for efaroxan and Astrocytosis

Article	Year
Dissociation between morphine-induced spinal gliosis and analgesic tolerance by ultra-low-dose α2-adrenergic and cannabinoid CB1-receptor antagonists. Behavioural pharmacology, 2018, Volume: 29, Issue:2 and 3-Sp Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics; Analgesics, Opioid; Animals; Benzofurans; Cannabinoid Receptor Antagonists; Cannabinoids; Dose-Response Relationship, Drug; Drug Tolerance; Gliosis; Imidazoles; Injections, Spinal; Male; Morphine; Neuroglia; Norepinephrine; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Spine	2018

Article

Year

Dissociation between morphine-induced spinal gliosis and analgesic tolerance by ultra-low-dose α2-adrenergic and cannabinoid CB1-receptor antagonists.

Behavioural pharmacology, 2018, Volume: 29, Issue:2 and 3-Sp

Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics; Analgesics, Opioid; Animals; Benzofurans; Cannabinoid Receptor Antagonists; Cannabinoids; Dose-Response Relationship, Drug; Drug Tolerance; Gliosis; Imidazoles; Injections, Spinal; Male; Morphine; Neuroglia; Norepinephrine; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Spine

2018